Track topics on Twitter Track topics that are important to you
1. Randomized control trial of patients with metastatic pancreatic adenocarcinoma demonstrates that adjuvant therapy with a modified FOLFIRINOX regimen results in significantly longer disease-free survival and median overall survival rates as compared to traditional gemcitabine therapy. 2. Higher rates of adverse events were noted among patients randomized to the FOLFIRINOX group. Evidence Rating Level: 1 […]NEXT ARTICLE
Pancreatitis Acute pancreatitis is inflammation of the pancreas caused by the release of activated pancreatic enzymes. Common triggers are biliary tract disease and chronic heavy alcohol intake. Diagnosis is based on clinical presentation...